FI102381B1 - Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä - Google Patents
Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessäInfo
- Publication number
- FI102381B1 FI102381B1 FI910587A FI910587A FI102381B1 FI 102381 B1 FI102381 B1 FI 102381B1 FI 910587 A FI910587 A FI 910587A FI 910587 A FI910587 A FI 910587A FI 102381 B1 FI102381 B1 FI 102381B1
- Authority
- FI
- Finland
- Prior art keywords
- ebna
- epstein
- barr virus
- nuclear antigen
- antibodies
- Prior art date
Links
- 108010008655 Epstein-Barr Virus Nuclear Antigens Proteins 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 238000002405 diagnostic procedure Methods 0.000 abstract 3
- 239000000427 antigen Substances 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 230000001154 acute effect Effects 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 201000006747 infectious mononucleosis Diseases 0.000 abstract 1
- 229920005604 random copolymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/230,250 US5717065A (en) | 1984-08-08 | 1988-08-09 | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| US23025088 | 1988-08-09 | ||
| PCT/US1989/003350 WO1990001495A1 (en) | 1988-08-08 | 1989-08-03 | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| US8903350 | 1989-08-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI910587A0 FI910587A0 (fi) | 1991-02-07 |
| FI102381B1 true FI102381B1 (fi) | 1998-11-30 |
| FI102381B FI102381B (fi) | 1998-11-30 |
Family
ID=22864499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI910587A FI102381B (fi) | 1988-08-09 | 1991-02-07 | Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi k udosnäytteessä |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5717065A (pt) |
| EP (1) | EP0428629B1 (pt) |
| AT (1) | ATE134648T1 (pt) |
| AU (1) | AU643188B2 (pt) |
| CA (1) | CA1340446C (pt) |
| DE (1) | DE68925819T2 (pt) |
| DK (1) | DK175828B1 (pt) |
| ES (1) | ES2018909A6 (pt) |
| FI (1) | FI102381B (pt) |
| GR (1) | GR890100501A (pt) |
| NO (1) | NO309720B1 (pt) |
| PT (1) | PT91397B (pt) |
| WO (1) | WO1990001495A1 (pt) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991008224A1 (en) * | 1989-11-24 | 1991-06-13 | The Council Of The Queensland Institute Of Medical Research | Im peptides |
| JPH04310861A (ja) * | 1991-04-09 | 1992-11-02 | Kazuo Yanagi | 抗ｅｂｎａ抗体の測定方法および抗ｅｂｎａ抗体測定キット |
| WO1994006912A1 (en) * | 1992-09-14 | 1994-03-31 | Akzo Nobel N.V. | Epstein-barr virus peptides and antibodies against these peptides |
| US5833991A (en) * | 1995-04-10 | 1998-11-10 | Cobra Therapeutics, Ltd. | Glycine-containing sequences conferring invisibility to the immune system |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4686282A (en) * | 1983-08-12 | 1987-08-11 | Immunetech, Inc. | Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors |
| US5116725A (en) * | 1984-08-08 | 1992-05-26 | Scripps Clinic And Research Foundation | Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides |
| US4654419A (en) * | 1984-08-08 | 1987-03-31 | Scripps Clinic And Research Foundation | Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| ZA846192B (en) * | 1984-08-09 | 1986-03-26 | Merck Patent Gmbh | Immunotherapeutic polypeptide agents |
-
1988
- 1988-08-09 US US07/230,250 patent/US5717065A/en not_active Expired - Lifetime
-
1989
- 1989-08-03 AU AU44000/89A patent/AU643188B2/en not_active Ceased
- 1989-08-03 EP EP89911450A patent/EP0428629B1/en not_active Expired - Lifetime
- 1989-08-03 AT AT89911450T patent/ATE134648T1/de not_active IP Right Cessation
- 1989-08-03 WO PCT/US1989/003350 patent/WO1990001495A1/en active IP Right Grant
- 1989-08-03 DE DE68925819T patent/DE68925819T2/de not_active Expired - Fee Related
- 1989-08-04 CA CA 607544 patent/CA1340446C/en not_active Expired - Lifetime
- 1989-08-07 PT PT91397A patent/PT91397B/pt not_active IP Right Cessation
- 1989-08-08 GR GR890100501A patent/GR890100501A/el unknown
- 1989-08-08 ES ES8902818A patent/ES2018909A6/es not_active Expired - Fee Related
-
1991
- 1991-02-07 FI FI910587A patent/FI102381B/fi active
- 1991-02-07 NO NO910479A patent/NO309720B1/no unknown
- 1991-02-07 DK DK199100211A patent/DK175828B1/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CA1340446C (en) | 1999-03-16 |
| EP0428629A4 (en) | 1991-12-27 |
| PT91397B (pt) | 1995-05-04 |
| ES2018909A6 (es) | 1991-05-16 |
| DK21191A (da) | 1991-04-04 |
| AU643188B2 (en) | 1993-11-11 |
| AU4400089A (en) | 1990-03-05 |
| FI910587A0 (fi) | 1991-02-07 |
| US5717065A (en) | 1998-02-10 |
| EP0428629A1 (en) | 1991-05-29 |
| NO910479L (no) | 1991-04-05 |
| GR890100501A (el) | 1991-12-30 |
| ATE134648T1 (de) | 1996-03-15 |
| EP0428629B1 (en) | 1996-02-28 |
| WO1990001495A1 (en) | 1990-02-22 |
| DK175828B1 (da) | 2005-03-14 |
| NO309720B1 (no) | 2001-03-19 |
| DE68925819T2 (de) | 1996-10-02 |
| PT91397A (pt) | 1990-03-08 |
| DE68925819D1 (de) | 1996-04-04 |
| FI102381B (fi) | 1998-11-30 |
| DK21191D0 (da) | 1991-02-07 |
| NO910479D0 (no) | 1991-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9202645D0 (en) | Synthetic antigenes applicables for detecting antibodies of hepatitis c virus | |
| DK532284A (da) | Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser | |
| FI20021626A (fi) | Immuunimäärityksen reagenssi ja menetelmä hepatiitti C-viruksen (HCV) vasta-aineiden havaitsemiseksi | |
| NZ219113A (en) | Hiv peptide containing epitope of the env protein | |
| ES545971A0 (es) | Un metodo para analizar los anticuerpos anti-ebna en una muestra corporal. | |
| ES2082775T4 (es) | Anticuerpos de proteinas latentes de papilomavirus humano, sistemas de diagnostico y procedimientos. | |
| EP0284587A3 (en) | Synthetic peptide antigens for the detection of hiv-1 infection | |
| GR3018371T3 (en) | Method for identifying or determining proteins and applications therefor. | |
| DE69033080D1 (de) | Zuwachsfaktorrezeptorgen deriviert von platten des typs oc | |
| FI102381B1 (fi) | Epstein-Barrin viruksen tuma-antigeeniin (EBNA) liittyviä synteettisiä polypeptidejä ja menetelmä anti-EBNA-vasta-aineiden tunnistamiseksi kudosnäytteessä | |
| DE59610867D1 (de) | Rekombinante autologe Fusionsproteine des Epstein-Barr-Virus, diese enthaltende Testkits und Verfahren zum Nachweis von Epstein-Barr-Virus-spezifischen Antikörpern | |
| SG145521A1 (en) | Synthetic antigens for the detection of antibodies to hepatitis c virus |